Forbes Names Quintiles One of America’s Best Employers
2015年3月26日 - 12:35AM
ビジネスワイヤ(英語)
Ranked 30th Overall, 3rd in Drugs & Biotech
Category
Quintiles, the world’s largest biopharmaceutical services
company, has been named to Forbes magazine’s first-ever “America’s
Best Employers” list as rated by more than 20,000 independent
survey responses.
Garrett Walker, Quintiles Chief Human
Resources Officer (Photo: Business Wire)
Quintiles is ranked as the 30th best employer in the United
States and comes in third in the “Drugs and Biotechnology”
category. In all, 500 companies are included in the 2015 Forbes
list.
“Being named one of the top employers in the U.S. is a great
honor for Quintiles and says a lot about our values, our people and
company mission,” said Chief Human Resources Officer Garrett
Walker. “Our organization is committed to building and sustaining a
work environment that enables our talent to be high performing,
successful in achieving their professional development goals and
provides multiple career paths and opportunities.”
Forbes’ Methodology
The Forbes ranking of top employers is drawn from an online
survey of 20,000 American workers at large U.S. companies,
nonprofit institutions such as hospitals, government agencies, and
U.S. divisions of multinationals, asking them to provide their
opinions on their employers and others in their industry with which
they were familiar.
Surveyed employees were asked, “On a scale of 1-10, how likely
would you be to recommend your employer to someone else? How about
other employers in your industry?”
Forbes’ statistics partner, Statista, evaluated the data and
identified 3,500 employers for whom there was a statistically
relevant result. From that pool, the top 500 companies made the
Forbes list. Those 500 were split up into 27 industry categories
covering all aspects of the American economy.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s
largest provider of biopharmaceutical development and commercial
outsourcing services. With a network of more than 32,000 employees
conducting business in approximately 100 countries, we helped
develop or commercialize all of 2013’s top-100 best-selling drugs
on the market. Quintiles applies the breadth and depth of our
service offerings along with extensive therapeutic, scientific and
analytics expertise to help our customers navigate an increasingly
complex healthcare environment as they seek to improve efficiency
and effectiveness in the delivery of better healthcare outcomes. To
learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20150325005980/en/
QuintilesPhil Bridges, Media Relations+1-919-998-1653,
+1-919-457-6347 (mobile)phil.bridges@quintiles.comorKarl Deonanan,
Investor
Relations+1-919-998-2789InvestorRelations@quintiles.com
Qimonda AG Ads (NYSE:QI)
過去 株価チャート
から 7 2024 まで 8 2024
Qimonda AG Ads (NYSE:QI)
過去 株価チャート
から 8 2023 まで 8 2024